USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
A Product and Pipeline Analysis of the Global Hepatitis C Virus (HCV) Antiviral Market
A Product and Pipeline Analysis of the Global Hepatitis C Virus (HCV) Antiviral Market
All-oral Regimens Revolutionize the Market
RELEASE DATE
19-Jun-2014
19-Jun-2014
REGION
North America
North America
Research Code: NE16-01-00-00-00
SKU: LS00128-NA-MR_16969
$3,950.00
In stock
SKU
LS00128-NA-MR_16969
Description
This research service focuses on antiviral therapeutics for the treatment of the hepatitis C virus (HCV). A global product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HCV. Segmentation by drug class is provided, along with supporting information such as clinical trial timelines and results, key market developments, historical and projected launch timelines, and epidemiology. The information contained in this research was derived from published sources, including disease organizations; public health organizations; company publications including annual reports, SEC filings, and press releases; government public sources; and articles in scientific journals.
Table of Contents
Key Market Developments Since Q1 2013
Key Findings
Evolution of Standard of Care for HCV
Key Companies to Watch
Methodology and Scope
HCV Overview
Global Prevalence of Chronic HCV Infection by Region
Global HCV Genotype Distribution and Relative Prevalence
HCV Antiviral Market—Segmentation
HCV Antiviral Market—Segmentation (continued)
Competitive Landscape—Marketed Products and Products in Development
Competitive Landscape—All-oral Regimens Late Stage Clinical Data
Competitive Landscape—Projected Launch Timeline for Oral Regimens
Competitive Landscape—Major Phase 3 Trials for All-oral Regimens
Competitive Landscape—Major Phase 3 Trials for All-oral Regimens (continued)
Competitive Landscape—Late Stage Assets by Company and Class
Marketed Products Synopsis—Standard of Care
Marketed Products Synopsis—Add-on to Standard of Care
Marketed Products Synopsis—Global Introduction by Region
Marketed Products Synopsis—Global Introduction by Region (continued)
Pipeline Synopsis—All-oral Regimens in Clinical Development
Pipeline Synopsis—All-oral Regimens in Clinical Development (continued)
Pipeline Synopsis—All-oral Regimens in Clinical Development (continued)
Pipeline Synopsis—Late Stage Clinical Development Landscape
Pipeline Synopsis—Late Stage Clinical Development Landscape (continued)
Pipeline Synopsis—Late Stage Clinical Development Landscape (continued)
Pipeline Synopsis—Late Stage Clinical Development Landscape (continued)
Pipeline Synopsis—Late Stage Clinical Development Landscape (continued)
Pipeline Synopsis—Late Stage Clinical Development Landscape (continued)
Pipeline Synopsis—Early Clinical Development Landscape
Pipeline Synopsis—Early Clinical Development Landscape (continued)
Pipeline Synopsis—Early Clinical Development Landscape (continued)
Conclusions and Recommendations
Conclusions and Recommendations (continued)
Legal Disclaimer
Decision Support Database
Decision Support Database (continued)
Decision Support Database (continued)
Decision Support Database (continued)
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
This research service focuses on antiviral therapeutics for the treatment of the hepatitis C virus (HCV). A global product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HCV. Segmentation by drug class is provided, along with supporting information such as clinical trial timelines and results, key market developments, historical and projected launch timelines, and epidemiology. The information contained in this research was derived from published sources, including disease organizations; public health organizations; company publications including annual reports, SEC filings, and press releases; government public sources; and articles in scientific journals.
| No Index | Yes |
|---|---|
| Podcast | No |
| Author | Randy Budros |
| WIP Number | NE16-01-00-00-00 |
| Is Prebook | No |